Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jes Sanddal Lindholt

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Danish Medical Bulletin|December 3, 2010
Abdominal aortic aneurysmsJes Sanddal Lindholt
Heart (British Cardiac Society)|January 23, 2021
Why and when to screen for cardiovascular disease in healthy individualsJes Sanddal Lindholt, Rikke Søgaard
Basic & Clinical Pharmacology & Toxicology|April 22, 2021
Fluoroquinolones as a trigger for rupture of abdominal aortic aneurysm: A case-crossover analysisKatrine Lawaetz Kristensen, Jesper Hallas, Jes Sanddal Lindholt
Journal of Vascular Surgery|April 20, 2025
Artificial intelligence in vascular surgery: Bridging technology and clinical practiceJoachim Sejr Skovbo, Lasse Møllegaard Obel, Jes Sanddal Lindholt
Ugeskrift for Laeger|April 16, 2015
[Atherectomy for peripheral arterial disease]Louise Skovgaard Londero, Annette Langager Høgh, Jes Sanddal Lindholt
Ugeskrift for Laeger|January 6, 2006
[Intermittent claudication]Martin Bach Jensen, Charlotte Buchard Nørager, Jes Sanddal Lindholt
The Patient|June 6, 2019
Do Non-participants at Screening have a Different Threshold for an Acceptable Benefit-Harm Ratio than Participants? Results of a Discrete Choice ExperimentTina Birgitte Hansen, Jes Sanddal Lindholt, Axel Diederichsen, et al.
Plos One|June 27, 2022
Individualized prediction of risk of ascending aortic syndromesQais Waleed Saleh, Axel Cosmus Pyndt Diederichsen, Jes Sanddal Lindholt
Arteriosclerosis, Thrombosis, and Vascular Biology|February 11, 2017
Glycated Hemoglobin Is Associated With the Growth Rate of Abdominal Aortic Aneurysms: A Substudy From the VIVA (Viborg Vascular) Randomized Screening TrialKatrine Lawaetz Kristensen, Marie Dahl, Lars Melholt Rasmussen, et al.
Journal of Translational Medicine|June 10, 2018
Microfibrillar-associated protein 4 variation in symptomatic peripheral artery diseaseLine Ea Hemstra, Anders Schlosser, Jes Sanddal Lindholt, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Danish Medical Bulletin|December 3, 2010
Abdominal aortic aneurysmsJes Sanddal Lindholt
Heart (British Cardiac Society)|January 23, 2021
Why and when to screen for cardiovascular disease in healthy individualsJes Sanddal Lindholt, Rikke Søgaard
Basic & Clinical Pharmacology & Toxicology|April 22, 2021
Fluoroquinolones as a trigger for rupture of abdominal aortic aneurysm: A case-crossover analysisKatrine Lawaetz Kristensen, Jesper Hallas, Jes Sanddal Lindholt
Journal of Vascular Surgery|April 20, 2025
Artificial intelligence in vascular surgery: Bridging technology and clinical practiceJoachim Sejr Skovbo, Lasse Møllegaard Obel, Jes Sanddal Lindholt
Ugeskrift for Laeger|April 16, 2015
[Atherectomy for peripheral arterial disease]Louise Skovgaard Londero, Annette Langager Høgh, Jes Sanddal Lindholt
Ugeskrift for Laeger|January 6, 2006
[Intermittent claudication]Martin Bach Jensen, Charlotte Buchard Nørager, Jes Sanddal Lindholt
The Patient|June 6, 2019
Do Non-participants at Screening have a Different Threshold for an Acceptable Benefit-Harm Ratio than Participants? Results of a Discrete Choice ExperimentTina Birgitte Hansen, Jes Sanddal Lindholt, Axel Diederichsen, et al.
Plos One|June 27, 2022
Individualized prediction of risk of ascending aortic syndromesQais Waleed Saleh, Axel Cosmus Pyndt Diederichsen, Jes Sanddal Lindholt
Arteriosclerosis, Thrombosis, and Vascular Biology|February 11, 2017
Glycated Hemoglobin Is Associated With the Growth Rate of Abdominal Aortic Aneurysms: A Substudy From the VIVA (Viborg Vascular) Randomized Screening TrialKatrine Lawaetz Kristensen, Marie Dahl, Lars Melholt Rasmussen, et al.
Journal of Translational Medicine|June 10, 2018
Microfibrillar-associated protein 4 variation in symptomatic peripheral artery diseaseLine Ea Hemstra, Anders Schlosser, Jes Sanddal Lindholt, et al.
Pageof 7